Bourgeois S, Newby R F, Huet M
Cancer Res. 1978 Nov;38(11 Pt 2):4279-84.
The thymoma line W7 contains 30,000 dexamethasone-binding sites per cell and gives rise to glucocorticoid-resistant variants at a frequency less than 1.6 X 10(-9); the lymphoma S49 contains one-half that amount of receptor, is resistant to low concentrations of dexamethasone, and gives rise to fully resistant variants at high frequency. These results suggest that S49 is functionally haploid (r+/-) for a gene coding for the receptor while W7 appears diploid for that locus (r+/+). Derivatives of the W7 (r+/+) line, selected for resistance to low concentrations of dexamethasone, have the same properties as S49. These putative W7's (r+/-) give rise to the same types of receptor variants as S49 and in the same proportion; 80 to 90% are "receptorless" (r-) while 10 to 20% are "nuclear transfer defective" (nt-). A total of 127 variants resistant to high concentrations of dexamethasone were derived from the W7 (r+/+) line after mutagenesis. All are receptor variants but N-methyl-N'-nitro-N-nitrosoguanidine and ethyl methanesulfonate induce only 60 to 70% r- variants, confirming the presence of two r+ alleles in the parental line. Ultraviolet light induces a higher proportion (87%) of r+ variants, as expected from the introduction of breaks and deletions in DNA.
胸腺瘤系W7每个细胞含有30,000个地塞米松结合位点,产生糖皮质激素抗性变体的频率低于1.6×10(-9);淋巴瘤S49含有该受体量的一半,对低浓度地塞米松有抗性,并以高频率产生完全抗性变体。这些结果表明,S49对于编码该受体的基因在功能上是单倍体(r+/-),而W7在该位点似乎是二倍体(r+/+)。从W7(r+/+)系中选择出对低浓度地塞米松有抗性的衍生物,其具有与S49相同的特性。这些假定的W7(r+/-)产生与S49相同类型的受体变体,且比例相同;80%至90%是“无受体”(r-),而10%至20%是“核转运缺陷”(nt-)。诱变后,从W7(r+/+)系中总共获得了127个对高浓度地塞米松有抗性的变体。所有都是受体变体,但N-甲基-N'-硝基-N-亚硝基胍和甲磺酸乙酯仅诱导60%至70%的r-变体,证实亲本品系中存在两个r+等位基因。如预期的那样,紫外线诱导更高比例(87%)的r+变体,这是由于DNA中出现断裂和缺失所致。